Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Potential Role of Acupuncture Treatment in Neuronal and Network Dysfunction in Patients With Vascular Cognitive Impairment

1. oktober 2019 opdateret af: Chang Gung Memorial Hospital

Vascular cognitive impairment (VCI) is a broad dimensional term, ranging from mild cognitive impairment without incapacity on activity of daily living to vascular dementia (VaD), referred to as significant cognitive impairment and decline in function status.

In this three-year project, we aim to evaluate the effects of biochemical data, early clinical variables, neuroimaging results, and intervention of acupuncture treatment on vascular event related cognitive impairment in crossectional analysis and longitudinal follow-up.

Studieoversigt

Status

Ukendt

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Stroke is a common cerebrovascular disease of the central nervous system leading to serious medical complication. It results in a high mortality rate and increased disability rate. Stroke survivors may have long-lasting consequences, including motor dysfunction, sensibility dysfunction, and cognitive impairment]. Cognition is a key component of rehabilitation and recovery; therefore it is associated with poor engagement in rehabilitee and outcomes including increased mortality. As vascular dementia (VaD) is considered the second-most-common type of dementing illness, accounting for a significant proportion of total dementia case, vascular cognitive impairment (VCI) is a broader dimensional term, ranging from mild cognitive impairment without incapacity on activity of daily living to VaD, referred to as significant cognitive impairment and decline in function status.

Acupuncture is an ancient Chinese medical technique in which fine, stainless steel needles are inserted into certain anatomical locations of the body surface to elicit neurohormonal responses of the body system via nerve stimulation. Acupuncture are reported to be probably effective in improving cognitive function in vascular dementia animal models via multiple mechanisms such as anti-apoptosis, antioxidative stress reaction, and metabolism enhancing of glucose and oxygen.

Motor features may not parallel to the cognitive changes, it will serve as the disease progression marker. Unified Parkinson's Disease Rating Scale (UPDRS)-part III scores and NIH Stroke Scale (NIHSS) will be used.

  1. At Kaohsiung Chang Gung Memorial Hospital, all the patients (n=80) will be included and receive a Standardized Acupuncture intervention; 40 will be treated with regular medication; 40 will be treated with acupuncture and regular medication.
  2. For acupressure program, all participants are treated in supine position, and a certified TCM physician applied firm pressure (3 to 5 kg of pressure) with fingertips in a circular motion at a speed of 2 circles per second for a duration of one minute per acupoint. The complete process lasts for 8 minutes.

Cognitive function, Motor function, Mood and Sleep will be evaluated at baseline and follow-up period of time at 3 month, 6 month, and 12 month.

Undersøgelsestype

Interventionel

Tilmelding (Forventet)

80

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Taiwan
      • Kaohsiung, Taiwan, 83301
        • Rekruttering
        • Kaohsiung Chang Gung Memorial Hospital
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

50 år til 80 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

1. Fulfill the diagnostic criteria of vascular cognitive impairment

Exclusion Criteria:

  1. Systemic inflammatory disease with on-going treatment
  2. Severe psychiatric disease, such as major depressive disorder or schizophrenia
  3. Severe traumatic brain injury
  4. Unable to tolerate exam of brain MRI

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Tredobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Sham-komparator: regular medication treatment
Enhed: Acupuncture
acupuncture treatment on selected acupoint
Eksperimentel: acupuncture and regular medication treatment
Enhed: Acupuncture
acupuncture treatment on selected acupoint

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change from baseline sleep quality at 3 months, 6 months, 12 months
Tidsramme: 3 months, 6 months, 12 months
Analogous variables were extracted from actigraphy. The sleep variables collected were sleep start time, sleep end time, sleep duration, sleep efficiency, and wake after sleep onset time, and the activity variables collected were heart rate activity score,activity amount, and activity intensity
3 months, 6 months, 12 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change from baseline neuro-behavioral performances at 3 months, 6 months, 12 months
Tidsramme: 3 months, 6 months, 12 months
Cognitive Abilities Screening Instrument (CASI). In addition to general cognitive performance, CASI was used to evaluate specific domains, including short-term memory, attention and concentration, abstraction, visual construction, language, and list-generating fluency.
3 months, 6 months, 12 months
Change from baseline motor function (UPDRS) at 3 months, 6 months, 12 months
Tidsramme: 3 months, 6 months, 12 months
Unified Parkinson's Disease Rating Scale (UPDRS)-part III scores for parkinsonian features.
3 months, 6 months, 12 months
Change from baseline motor function (NIHSS) at 3 months, 6 months, 12 months
Tidsramme: 3 months, 6 months, 12 months
NIH Stroke Scale (NIHSS) score 0-24.
3 months, 6 months, 12 months
Change from baseline continuous motor function at 3 months, 6 months, 12 months
Tidsramme: 3 months, 6 months, 12 months
Physical activity was measured using accelerometers.
3 months, 6 months, 12 months
Change from baseline memory performances at 3 months, 6 months, 12 months
Tidsramme: 3 months, 6 months, 12 months
Verbal memory were evaluated by using Chinese Version Verbal Learning Test (CVVLT).Visual-spatial abilities.
3 months, 6 months, 12 months
Change from baseline executive performances at 3 months, 6 months, 12 months
Tidsramme: 3 months, 6 months, 12 months
Attention and executive function was evaluated by Trail Making Test B.
3 months, 6 months, 12 months
Change from baseline executive performances (Stroop interference test) at 3 months, 6 months, 12 months
Tidsramme: 3 months, 6 months, 12 months
Attention and executive function was evaluated by Stroop interference test.
3 months, 6 months, 12 months
Change from baseline executive performances (calculation) at 3 months, 6 months, 12 months
Tidsramme: 3 months, 6 months, 12 months
As the calculation ability depends on executive function, calculation ability was evaluated to reflect part of executive function.
3 months, 6 months, 12 months
Change from baseline abstract thinking at 3 months, 6 months, 12 months
Tidsramme: 3 months, 6 months, 12 months
Abstract reasoning was evaluated by using similarities (conceptualization) in frontal assessment battery-Similarities.
3 months, 6 months, 12 months
Change from baseline language performances at 3 months, 6 months, 12 months
Tidsramme: 3 months, 6 months, 12 months
Boston Naming Test were used to evaluate language ability in naming.
3 months, 6 months, 12 months
Change from baseline fluency performances at 3 months, 6 months, 12 months
Tidsramme: 3 months, 6 months, 12 months
Semantic category fluency.
3 months, 6 months, 12 months
Change from baseline neuropsychiatric symptoms at 3 months, 6 months, 12 months
Tidsramme: 3 months, 6 months, 12 months
The neuropsychiatric symptoms of the participants were measured using the Neuropsychiatric Inventory.
3 months, 6 months, 12 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Chang Gung Memorial Hospital

Efterforskere

  • Ledende efterforsker: YaTing Chang, MD,PhD, Chang Gung Memorial Hospital

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. september 2019

Primær færdiggørelse (Forventet)

1. september 2020

Studieafslutning (Forventet)

1. juli 2022

Datoer for studieregistrering

Først indsendt

18. august 2019

Først indsendt, der opfyldte QC-kriterier

11. september 2019

Først opslået (Faktiske)

12. september 2019

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

3. oktober 2019

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

1. oktober 2019

Sidst verificeret

1. august 2019

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 201802103A3

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Vaskulær kognitiv svækkelse

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Philippines

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner